Table of Contents Table of Contents
Previous Page  56 / 78 Next Page
Information
Show Menu
Previous Page 56 / 78 Next Page
Page Background

56

Vol. 66, No. 4 2015

Northeast Florida Medicine

DCMS online

. org

CME

The Role of a Primary Care Physician in the

Management of Inflammatory Bowel Disease

Introduction

The Primary Care Physician (PCP) plays a very import-

ant role in the management of patients with Inflammatory

Bowel Disease (IBD), acting much like a copilot to the

gastroenterologist, and at times taking over the role of a

pilot. Some patients are hesitant to follow up with their

PCP, claiming that they have no other medical problems,

but most gastroenterologists find that the best outcomes

are obtained in patients whose PCP is closely involved

with their care. Gastroenterologists sometimes develop

a tunnel vision in treating these patients and PCPs can

help them in refocusing on the whole patient.

When to suspect IBD and refer patients?

The diagnosis of IBD can be difficult to make. There

is no single or specific test that makes a definitive diag-

nosis of IBD. The diagnosis is based on a combination of

clinical findings, laboratory abnormalities, radiological

abnormalities, endoscopic findings, pathological features

and, more recently, serological markers. The mean delay

in diagnosis of IBD was 3.3 years in the past, but has

recently decreased to about a year.

1

PCPs should be vigilant

Abstract:

Primary Care Physicians (PCPs) play an important role

in the management of patients with IBD. They should know when

to suspect and refer patients with IBD, how to screen and treat for

bone loss, update all vaccinations, screen and treat for depression

and anxiety, when to consider screening for self-image, and how

to monitor and treat nutritional deficiencies. They should also

understand the role of NSAIDs, smoking and Clostridium difficile

infections. PCPs are critical to optimizing patient care and outcomes.

and refer patients who have symptoms, signs, laboratory

or radiological evidence of IBD. The cardinal symptoms

are abdominal pain, diarrhea and rectal bleeding. Some

patients have tenesmus, anorexia and weight loss. Crohn’s

disease patients may present with perianal disease or bowel

obstruction. These symptoms are usually of gradual onset

and may be intermittent. Examination may showmild pal-

lor, non-specific abdominal tenderness, and non-descript

perianal disease. Examination however is usually not very

impressive. A review of systems may reveal symptoms of

extra intestinal involvement. Lab work may be normal

or may reveal anemia, hypoalbuminemia, elevated C

reactive protein (CRP) or deficiencies of iron, folic acid

and vitamin B12. Stool studies may reveal presence of

occult blood, leucocytes, lactoferrin and calprotectin.

Infectious agents should be ruled out by appropriate

stool studies. A family history of IBD may help, but is

usually not present. Serological markers of IBD are not

very reliable or cost effective in the initial diagnosis.

1,2

Osteoporosis screening and treatment

Patients with IBD have a very high prevalence of

osteopenia and osteoporosis, which ranges from 18–42

percent.

3,4

Osteoporosis is more prevalent in Crohn’s

disease as compared to ulcerative colitis. Corticosteroid

treatment is a major risk factor and the risk of osteoporosis

is directly proportional to the lifetime use of corticoste-

roids. IBD-related chronic inflammation also predisposes

to osteoporosis. Hypogonadism, low vitamin D, calcium

malabsorption and malnutrition are also contributing

factors. Other lifestyle risk factors include smoking,

alcoholism, physical inactivity and obesity.

5

Postmeno-

pausal women and men over 50 are at increased risk.

6

The American Gastroenterological Association (AGA)

recommends a Bone Mineral Density (BMD) using a

DXA scan of the spine and hip in patients with IBD

who are at risk for bone loss and fracture.

3

If the BMD

is normal, it should be repeated in two to three years.

If abnormal, patients should be screened for secondary

causes of osteoporosis. Treatment should be initiated

By Bharat K. Misra, MD

Address correspondence to:

Bharat K. Misra, MD

Borland Groover Clinic

3627 University Boulevard South, Suite #705

Jacksonville, Fl 32216